This Article Abstract Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adams, J. W. Articles by Brown, J. H. Search for Related Content PubMed PubMed Citation Articles by Adams, J. W. Articles by Brown, J. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Apoptosis Cell signalling/signal transduction

(Circulation Research. 2000;87:1180.)
© 2000 American Heart Association, Inc.

Cellular Biology

Cardiomyocyte Apoptosis Induced by Gq Signaling Is Mediated by Permeability Transition Pore Formation and Activation of the Mitochondrial Death Pathway

John W. Adams, Amy L. Pagel, Christopher K. Means, Donna Oksenberg, Robert C. Armstrong, Joan Heller Brown

From the Department of Pharmacology (J.W.A., A.P., C.K.M., J.H.B.), University of California, San Diego, La Jolla, Calif; Idun Pharmaceuticals, Inc (R.C.A.), La Jolla, Calif; and COR Therapeutics, Inc (D.O.), South San Francisco, Calif.

Correspondence to Joan Heller Brown, Department of Pharmacology, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0636. E-mail jhbrown{at}ucsd.edu

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
Abstract—Expression of the wild-type subunit of Gq stimulates phospholipase C and induces hypertrophy in cardiomyocytes. Addition of Gq-coupled receptor agonists additionally activates phospholipase C, as does expression of a constitutively active mutant form of Gq. Under these conditions, hypertrophy is rapidly succeeded by apoptotic cellular and molecular changes, including myofilament disorganization, loss of mitochondrial membrane potential, alterations in Bcl-2 family protein levels, DNA fragmentation, increased caspase activity (4-fold), cytochrome c redistribution, and nuclear chromatin condensation in 12% of the cells. We used various interventions to define the molecular relationships between these events and identify potential sites at which these features of apoptosis could be rescued. Treatment with caspase inhibitors prevented DNA fragmentation and promoted myocyte survival; however, cytochrome c release and loss of mitochondrial membrane potential still occurred. In contrast, treatment with bongkrekic acid, an inhibitor of the mitochondrial permeability transition pore, not only prevented DNA fragmentation and reduced nuclear chromatin condensation but also preserved mitochondrial membrane potential and limited cytochrome c redistribution to only 2% of cells. These data demonstrate the central role of mitochondrial membrane potential in initiation of caspase activation and downstream apoptotic events and suggest that preservation of mitochondrial integrity is crucial for prolonging the life and function of cardiomyocytes exposed to pathological levels of stress.

Key Words: cardiomyocyte • apoptosis • mitochondria • G proteins

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
In the last several years, in vitro and in vivo experiments have established a pivotal role for the heterotrimeric G protein, Gq, in initiating activation of intracellular growth-signaling pathways in cardiac myocytes. For example, studies using cultured neonatal rat ventricular myocytes have demonstrated that many hormones or growth factors that couple to Gq to activate phospholipase C stimulate cardiomyocyte hypertrophy.^{1 2 3 4} We showed previously that adenovirus-mediated overexpression of the wild-type subunit of Gq can also induce cardiomyocyte hypertrophy.⁵

Transgenic mice expressing a modestly increased (4-fold) level of Gq in the heart manifest a stable cardiac hypertrophy, whereas transgenic mice with higher levels of Gq overexpression (8-fold) develop a dilated cardiomyopathy.⁶ In addition, the hypertrophy seen in mice overexpressing Gq at modest levels rapidly transitioned into a lethal dilated cardiomyopathy in females during the stress associated with pregnancy and parturition⁵ and in Gq-expressing mice subjected to aortic banding (J.W. Adams, J. Ross, Jr, unpublished data, 2000). Expression of a constitutively activated form rather than a wild-type form of Gq (GqWT) in the hearts of transgenic mice was also found to result in a dilated cardiomyopathy.⁷ Cardiomyocyte apoptosis occurs in all of these models in which it was examined, suggesting that it contributes to the observed cardiomyopathies. Consistent with this, expression of activated Gq or stimulation of the Gq-coupled angiotensin II receptor induces apoptosis in isolated cardiomyocytes.^{5 8}

It has been hypothesized that loss of contractile function in the overloaded heart may result, at least in part, from myocyte dropout attributable to apoptotic cell death. However, despite substantial evidence for a role of apoptosis in the pathogenesis of heart failure, its biochemical triggers have not been identified. Recently, it was demonstrated that moderate heart failure after myocardial infarction in rats is associated with upregulation of the expression of Gq and phospholipase C (PLC)-ß.⁹ Additionally, many of the neurohumoral activators of Gq signaling (eg, catecholamines, endothelin, prostaglandin F₂ [PGF₂], and angiotensin II) are also elevated in the failing myocardium.¹⁰ These observations led us to examine mechanisms by which Gq signaling might trigger apoptosis and thereby contribute to heart failure.

Apoptosis is distinguished from necrosis by several morphological and biochemical criteria, including proteolytic activation of caspases. Recent evidence points to the mitochondria as a critical trigger for caspase activation in mammalian cells.¹¹ In response to a variety of stimuli, proapoptotic signals converge on the mitochondria to provoke the release of cytochrome (cyto) c and other factors, which combine in the cytoplasm to initiate caspase activation.¹¹ Cyto c release has been associated with changes in mitochondrial membrane permeability secondary to loss of mitochondrial membrane potential (_m). Recently, a pivotal role for the mitochondrial permeability transition (PT) pore as a mechanism for loss of _m was shown.¹²

Mitochondrial cyto c release has been observed in several models of cardiomyocyte apoptosis,^{13 14 15 16 17} but the importance of mitochondria as a target for preserving cardiomyocyte function has not been clearly examined. In this study, we demonstrate the involvement of the mitochondrial pathway as an upstream event in apoptotic signaling induced by activation of Gq and present the first evidence that inhibition of the mitochondrial PT rescues cardiomyocytes from apoptotic cell death.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
More detailed methods are described in the online data supplement, available at http://www.circresaha.org, and in published studies, as referenced.

Neonatal cell culture,^{18 19} phosphoinositide hydrolyisis,²⁰ generation of recombinant adenoviruses,^{5 21} DNA fragmentation,⁵ electron microscopy,²² and immunoblotting³ were performed as described previously. Methods for assessment of caspase activity and inhibition experiments are described in the online data supplement.

Adenoviral Constructs
Adenoviral constructs were prepared in our laboratory from expression plasmids encoding wild-type, constitutively active Gq (GqQ209L), generated by Dr Gary Johnson (University of Colorado), and a mutant form of activated Gq (GqDNE/AAA), obtained from Dr John Exton (Vanderbilt University, Nashville, Tenn).²³ AdBcl-xl was obtained from Dr Gianluigi Condorelli (Thomas Jefferson University, Philadelphia, Pa).

Inhibitors and Antibodies
Idun 1965 was synthesized and characterized at Idun Pharmaceuticals.²⁴ ZVAD-fmk and bongkrekic acid (BA) were obtained commercially (Calbiochem). Antibodies for Bcl-2 and Bcl-xl were obtained from Transduction Laboratories; Bad and Bax antibodies were obtained from Santa Cruz.

Immunocytochemistry and Cyto c Redistribution
Cells were fixed, permeabilized, blocked, and incubated sequentially with a mouse monoclonal antibody against cyto c (Pharmingen) and an Alexa 594–conjugated goat anti-mouse IgG (Molecular Probes). Myocyte nuclei and sarcomeres (F-actin) were stained concurrently with Hoechst 33342 (Molecular Probes) and FITC-conjugated phalloidin (Molecular Probes). Cyto c localization, sarcomere organization, and nuclear structure were visualized on a Zeiss Axiovert fluorescence microscope. Alternatively, multispectral digital images of fluorescent cellular structures were visualized using a deconvolution microscope (Nikon).

Measurement of _m
m was assessed using JC-1²⁵ (10 µmol/L) and MitoTracker Red CMXRos (200 nmol/L) staining at 37°C for 10 minutes. Cover slips with attached live (unfixed) cells were inverted onto glass slides for microscopy. Multispectral digital images of fluorescent cellular structures were visualized by deconvolution microscopy. Alternatively, myocytes stained with MitoTracker Red were collected by trypsinization (0.05% Trypsin, 0.53 mmol/L EDTA) and prepared for quantitative analysis of _m by flow cytometry.

Statistical Analysis
Results are reported as mean±SEM. Statistical significance was determined using ANOVA with Newman-Keuls correction for multiple comparisons. A P value of <0.05 was considered statistically significant.

An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Adenovirus-Mediated Expression of Gq Activates PLC
We previously reported that constitutively activated Gq expression leads to a marked increase in PLC activity and subsequent myocyte apoptosis.⁵ Stimulating endogenous Gq-coupled receptors in cells overexpressing GqWT elicited a comparable level of PLC activation (Figure 1). Thus, although overexpression of GqWT or stimulation with PGF₂ caused a 10- to 15-fold increase in inositol phosphate formation, addition of PGF₂ (or phenylephrine; data not shown) to GqWT-overexpressing myocytes increased PLC activation to the level induced by constitutively activated Gq (GqQ209L).

View larger version (13K): [in this window] [in a new window]   Figure 1. Figure 1. Phosphoinositide hydrolysis is increased by constitutively activated Gq or agonist-enhanced Gq signaling. Myocytes were infected with indicated adenovirus constructs and labeled with 2 µCi/mL [3H]-myoinositol for 24 hours in serum-free medium and then washed and switched to HEPES-buffered medium containing 10 mmol/L LiCl with or without 1 µmol/L PGF2 for 30 minutes. Cell lysates were run over ion exchange columns, and total inositol phosphates were eluted and incorporated label measured with a liquid scintillation counter. Data represent average fold stimulation±SEM from 3 experiments, each done in triplicate. *P<0.05 vs control adenovirus (AdCtrl); #P<0.01 versus AdCtrl/PGF2.

Enhanced Gq Signaling Causes Cardiomyocyte Apoptosis
To correlate the level of PLC activation with cardiomyocyte apoptosis, we measured oligonucleosomal DNA fragmentation in myocytes infected with either GqWT or activated Gq adenoviruses in the presence or absence of PGF₂. A striking increase in DNA fragmentation was seen with GqQ209L expression or when PGF₂ was added to GqWT-overexpressing cells (Figure 2A). To determine whether coupling to PLC was required for Gq-induced apoptosis, we infected myocytes with an adenovirus encoding an activated Gq mutated to inhibit coupling to PLC.²³ Significantly reduced hydrolysis of inositol phospholipids (10-fold above control versus 60-fold for GqQ209L) was seen when this mutant (GqDNE/AAA) was expressed in myocytes at levels similar to GqQ209L. Importantly, no apoptosis was observed in cells infected with this construct (data not shown). Furthermore, expression of a constitutively active mutant of the subunit of the heterotrimeric G protein, G_i, does not activate PLC, nor did it induce DNA fragmentation (Figure 2A). Thus, stimuli that cause high-level PLC activation are associated with apoptotic cell death, evidenced by the formation of oligonucleosomal-sized DNA fragments.

View larger version (48K): [in this window] [in a new window]   Figure 2. Figure 2. DNA fragmentation and caspase activation are increased by constitutively activated Gq or agonist-enhanced Gq signaling. A, DNA was isolated from myocytes infected with the indicated adenovirus constructs after incubation in the presence or absence of 1 µmol/L PGF2 for 48 hours. DNA samples were separated on 2% agarose gels, and fragmentation was detected by staining with ethidium bromide under ultraviolet light. Data are representative of at least 3 separate experiments. B, Myocytes infected with indicated adenovirus constructs were incubated in serum-free medium for 48 hours with or without addition of 1 µmol/L PGF2. Caspase activity was measured in cell lysates using the fluorogenic substrate DEVD-amc. Values represent the mean±SEM of triplicate reactions from 3 separate experiments and are expressed as the change in fluorescence units per minute per milligram of cellular protein. *P<0.01 vs AdCtrl.

Caspases Are Activated and Required for Gq-Induced Apoptosis
To determine if enhanced Gq signaling activated caspases, we measured cleavage of a caspase-specific fluorogenic substrate DEVD-amc. Caspase activity did not increase in cells that hypertrophied in response to PGF₂ or GqWT overexpression (Figure 2B). In contrast, a significant (4-fold) increase in caspase activity was seen in response to PGF₂ treatment of GqWT-overexpressing myocytes. A similar increase in caspase activity was seen in myocytes infected with GqQ209L.

To examine the involvement of caspase activation in Gq-induced cardiomyocyte apoptosis, we used Idun 1965, a broad-spectrum caspase inhibitor. Idun 1965 (10 µmol/L) was able to completely abolish caspase activation (DEVD-amc cleavage) induced by overexpression of GqQ209L in cardiac myocytes (data not shown). Notably, Idun 1965 completely blocked DNA fragmentation and dramatically reduced cell death induced by either constitutively active Gq or activation of GqWT by PGF₂ (Figures 3A and 3B). This inhibitor did not prevent increased myocyte size (Figure 3A) or sarcomere organization (not shown) in response to GqWT overexpression, demonstrating integrity of Gq signaling pathways and specificity for events in the apoptotic pathway rather than the hypertrophic pathways activated by Gq. ZVAD-fmk, another caspase inhibitor, also inhibited Gq-induced DNA fragmentation and cell death (not shown).

View larger version (70K): [in this window] [in a new window]   Figure 3. Figure 3. Caspase inhibitors block Gq-induced DNA fragmentation and cell death. Myocytes were infected with indicated adenovirus constructs in the absence or presence of 10 µmol/L Idun 1965. After washing, cells were incubated in serum-free medium with fresh inhibitor for an additional 48 hours. A, Before DNA isolation, cells were photographed using phase contrast to demonstrate increased cell survival in GqQ209L-infected myocytes and hypertrophy in GqWT-infected myocytes treated with Idun 1965. Bar=25 µm. B, DNA was isolated, separated by electrophoresis, and analyzed for oligonucleosomal fragmentation under ultraviolet light.

Enhanced Gq Signaling Causes Mitochondrial Damage and Loss of _m
Electron microscopy revealed pronounced mitochondrial abnormalities in myocytes infected with GqQ209L. In the presence of intact plasma membranes, mitochondria of myocytes infected with GqQ209L appeared focally dilated and showed disrupted cristae (Figure 4A, white arrow) compared with normal mitochondria in myocytes infected with GqWT. In addition, the cytoplasm of virtually all myocytes expressing GqQ209L contained numerous large membrane-bound vacuoles (Figure 4A, black arrow). The origin and function of the vacuoles remain unknown, but lack of staining with either osmium tetroxide or Oil red-O suggests that they do not contain lipid (data not shown).

View larger version (91K): [in this window] [in a new window]   Figure 4. Figure 4. Mitochondrial abnormalities and vacuole formation in cardiac myocytes expressing activated Gq. A, Myocytes infected with indicated adenovirus constructs were incubated in serum-free medium for 48 hours and then fixed and prepared for electron microscopy. Healthy mitochondria (M) shown in GqWT-infected cells are contrasted with damaged mitochondria (white arrows) in GqQ209L-infected myocytes. Nuclear (N) changes and cytoplasmic vacuoles (black arrows) are also prominent in myocytes infected with GqQ209L. B, Myocytes infected with GqWT adenovirus (left) show red fluorescent JC-1 aggregates indicative of an intact m. In contrast, expression of GqQ209L (right) results in a reduction of JC-1 aggregate formation indicative of loss of m.

In light of the observed mitochondrial abnormalities, we asked whether GqQ209L expression also caused a decrease in _m. These studies were carried out using 2 potential sensitive mitochondrial dyes, JC-1 and MitoTracker Red. Hypertrophied myocytes expressing GqWT (Figure 4B), like AdCtrl-infected cells (not shown), showed punctate red staining, demonstrating formation of JC-1 aggregates and thus normal membrane potential in virtually every cell. Although it is difficult to quantitate JC-1 staining in live adherent cells, we reproducibly found a significant proportion of GqQ209L-expressing myocytes in which JC-1 aggregate formation was decreased, indicative of a loss of _m. Similarly, many myocytes observed after infection with GqQ209L demonstrated a decrease in fluorescence intensity after staining with the potential sensitive dye MitoTracker Red. This effect was confirmed by flow cytometry, where a loss of _m in myocytes infected with GqQ209L is indicated by the decrease in the population of myocytes with high-fluorescence intensity CMXRos staining (Figure 6A, right peak), as discussed in more detail below. Thus, enhanced Gq signaling stimulated by GqQ209L expression results in loss of _m in cardiomyocytes.

View larger version (23K): [in this window] [in a new window]   Figure 6. Figure 6. Gq-induced loss of m is blocked by inhibitors of PT pore but not by caspase inhibition. A, Myocytes were infected with indicated adenovirus constructs in the presence or absence of 50 µmol/L BA. After an additional 48-hour incubation in serum-free medium (pH 6.8)±fresh inhibitor, myocytes were stained for m with 200 nmol/L MitoTracker Red for 10 minutes, trypsinized, pelleted, and then resuspended and prepared for flow cytometry as described in Materials and Methods. Data are representative examples of at least 3 separate experiments. B, Myocytes were infected with GqQ209L adenovirus in the presence or absence of either 50 µmol/L BA or 10 µmol/L Idun 1965 (Idun). Overlay of data from an experiment in which the effects of BA or Idun on GqQ209L-induced loss of m were directly compared.

Enhanced Gq Signaling Causes Mitochondrial Cyto c Release
Redistribution of cyto c from the mitochondria to the cytosol was examined by immunocytochemical staining for cyto c. In virtually all cells infected with GqWT, cyto c fluorescence was contained within an extensive threadlike network surrounding the nucleus but extending deeply into the cytosol (Figure 5A). An identical pattern of staining was seen when MitoTracker Red was added to the culture medium, indicating that the localization of cyto c mirrors that of cardiomyocyte mitochondria (data not shown). In contrast, the association of cyto c with mitochondria was reduced in myocytes expressing GqQ209L. The immunocytochemical data are shown quantitatively in Figure 5B and indicate that 14% of the GqQ209L-expressing myocytes showed diffuse cyto c staining, with fluorescence visible throughout the cytoplasm and nucleus (Figure 5A, white arrow) rather than localized to the mitochondria. The same GqQ209L-infected myocytes that showed cytosolic redistribution of cyto c consistently demonstrated condensed nuclear chromatin (Hoechst) and loss of actin (phalloidin) organization (Figure 5A, white arrows). A similar effect on cyto c redistribution and nuclear condensation was seen in GqWT-overexpressing cells stimulated with PGF₂ (not shown).

View larger version (71K): [in this window] [in a new window]   Figure 5. Figure 5. Caspase-independent redistribution of cyto c from mitochondria to cytoplasm occurs in response to enhanced Gq signaling. A, Myocytes infected with indicated adenovirus constructs were incubated for 48 hours in serum-free medium then fixed and stained for cyto c (top), nuclear chromatin (middle), and F-actin (bottom). Fluorescent micrographs were obtained using 3 different filters without changing the viewing field. Note diffuse cyto c staining throughout the cytoplasm and nucleus (white arrow) in GqQ209L-infected cell and the corresponding nuclear chromatin condensation (Hoechst 33342) and loss of sarcomere organization (phalloidin) in the same cell. Similar redistribution of cyto c to the cytoplasm is seen in GqQ209L-infected cells treated with 10 µmol/L Idun 1965 (white arrowheads). Bar=10 µm. B, Myocytes were infected with indicated adenovirus constructs and incubated in the absence or presence of 10 µmol/L Idun 1965 for 48 hours. Cells were stained as in panel A, and 300 cells per treatment group were scored for cyto c release. Values represent mean±SEM of values from 3 separate experiments. *P<0.05 vs GqWT; **P<0.01 vs GqQ209L.

To determine whether caspase activation participates in the control of cyto c release, we examined the effect of Idun 1965 on cyto c localization in myocytes infected with GqQ209L. Idun 1965 did not decrease the percentage of myocytes with diffuse cytoplasmic cyto c staining. In fact, there was a significant increase in the number of myocytes with cytosolic cyto c in the presence of Idun 1965 (Figure 5A, arrowheads on cyto c panel, and Figure 5B). This can be explained by the fact that the GqQ209L-infected myocytes normally die and detach after cyto c release, whereas cells that release cyto c in the presence of the inhibitor remain attached and accumulate, contributing to the increased number of cells with cytosolic cyto c that can be counted. Surviving myocytes seem to have a normal nuclear appearance (Figure 5A, arrowheads on Hoechst stain) but lack organized myofilaments (Figure 5A, arrowheads on phalloidin stain). These observations demonstrate that caspase activation, although necessary for the nuclear changes leading to cell death, is not required for release of cyto c from mitochondria. Studies using MitoTracker Red also demonstrated that Idun 1965 had no effect on GqQ209L-induced disruption of _m (see below). Thus, our data demonstrate that activated caspases participate downstream of, but do not mediate, the mitochondrial permeability changes or cyto c release that occurs in response to enhanced G protein activation.

Bongkrekic Acid (BA) Prevents Gq-Induced Cyto c Release and Loss of _m and Inhibits Cardiomyocyte Apoptosis
Cyto c release has been attributed to loss of mitochondrial integrity initiated by opening of the mitochondrial PT pore. To examine the role of the PT pore in Gq-induced apoptosis, we tested the effects of BA, which has been shown to block mitochondrial PT.¹² As mentioned above, flow cytometry of cells stained with MitoTracker Red (CMXRos) revealed that GqQ209L led to a decrease in the number of myocytes with high-intensity fluorescence, indicating a subpopulation of cells in which membrane potential is diminished (Figure 6A). Although BA largely prevented the decreased fluorescence in this subpopulation of cells, inhibition of caspase activation with Idun 1965 had no protective effect (Figure 6B). Thus, the membrane potential change seems to be caused by PT activation but independent of caspase activation.

Blockade of PT and _m with BA was highly effective at preventing GqQ209L-induced cyto c release, reducing the fraction of cells demonstrating loss of mitochondrial cyto c from 10.4±3.0% to 1.9±0.9% (Figures 7A and 7B). The effect of BA was additionally assessed by examining changes in Gq-induced nuclear damage with Hoechst 33342. Consistent with its effect on cyto c release, BA treatment reduced the percentage of GqQ209L-infected myocytes with nuclear chromatin condensation from 12.2±3.8% to 2.2±1.0% (Figure 7B). Loss of myocyte attachment induced by GqQ209L was also blocked by BA treatment, indicating that cell death was prevented (data not shown). Finally, BA was able to reduce some of the early events associated with Gq-induced cardiomyocyte apoptosis, including vacuole formation and cell shrinkage (not shown). Another inhibitor of PT pore formation, cyclosporin A (5 to 50 µmol/L), was also able to reduce Gq-induced vacuole formation and cell shrinkage (data not shown). However, in contrast to what was observed with BA, the protective effect of cyclosporin A on cardiac myocytes was not sustained and death was not prevented.

View larger version (33K): [in this window] [in a new window]   Figure 7. Figure 7. BA blocks Gq-induced cyto c redistribution. A, Myocytes were infected with indicated adenovirus constructs in the presence or absence of 50 µmol/L BA in serum-free medium (pH 6.8). After an additional 48-hour incubation in serum-free medium (pH 6.8)±fresh BA, myocytes were fixed, permeabilized, and incubated with cyto c antibody, phalloidin, and Hoechst 33342, as described in Materials and Methods. Subcellular localization of cyto c (red), nuclear chromatin structure (blue), and sarcomere organization (green) were visualized for either cyto c and nuclear chromatin (A through C) or all 3 combined (D through F). Mitochondrial cyto c redistribution to the cytoplasm (white arrow) is best seen in the absence of FITC-phalloidin fluorescent staining (A through C). B, Myocytes were infected with indicated adenovirus constructs in the presence or absence of 50 µmol/L BA. After 48 hours of treatment, myocytes were fixed, stained, and scored for cyto c localization, chromatin condensation, and sarcomere organization, as described in Materials and Methods. Values represent averages±SEM for 3 separate experiments, where 300 cells were counted per treatment group. *P<0.05 vs Q209L without BA.

Gq-Induced Changes in Bcl-2 Family Protein Levels
To determine if Bcl-2 family protein levels are altered by increased Gq activity, we performed Western blots using antibodies specific for Bcl-2, Bcl-xl, Bax, and Bad. As shown in Figure 8A, expression of GqQ209L in myocytes dramatically decreased the protein levels of Bcl-2 and Bcl-xl, whereas Bad levels were increased. To determine if decreased levels of Bcl-xl were responsible for Gq-induced apoptosis, we infected myocytes with an adenovirus encoding Bcl-xl (AdBcl-xl). Bcl-xl protein levels were dramatically increased in myocytes infected with AdBcl-xl (Figure 8B). DNA fragmentation analysis demonstrated that overexpression of Bcl-xl completely blocked cardiomyocyte apoptosis induced by 2-deoxyglucose (Figure 8C). In contrast, Bcl-xl expression did not block Gq-induced DNA fragmentation. Similarly, overexpression of Bcl-2 by adenovirus exhibited no protective effect on Gq-induced apoptosis (data not shown). These results suggest that decreased cellular levels of Bcl-xl or Bcl-2 do not play a causal role in Gq-induced cardiomyocyte apoptosis. The role of increased Bad and potential changes in other Bcl-2 family proteins in Gq-induced apoptosis are presently under investigation.

View larger version (64K): [in this window] [in a new window]   Figure 8. Figure 8. Role of Bcl-2 family proteins in Gq-induced cardiomyocyte apoptosis. A, Cell lysates were prepared from myocytes infected with the indicated adenovirus constructs, and equal amounts of protein (30 µg) were separated by electrophoresis. Relative levels of Bcl-2 family proteins were assessed by Western blot analysis. B, Myocytes were infected with control adenovirus (AdCtrl) or adenovirus expressing Bcl-xl at the indicated multiplicity of infection expressed in viral particles per cell (vp/cell). Lysates were harvested and analyzed by Western blotting for Bcl-xl expression 24 hours after infection. C, Myocytes were coinfected with Bcl-xl and GqQ209L (Q209L) or control adenovirus (AdCtrl) or were infected with Bcl-xl 16 hours before treatment with 2 mmol/L 2-deoxyglucose (2-DOG). DNA was isolated after 24 hours of treatment, and oligonucleosomal fragmentation was assessed. Blots and gels are representative of at least 3 separate experiments.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
Recent studies have identified a role for caspases in cardiomyocyte apoptosis induced by staurosporine, reperfusion after ischemia, and serum and glucose deprivation.^{14 26 27} Our findings demonstrate that cardiomyocyte apoptosis induced by enhanced Gq signaling is likewise associated with a marked increase in caspase activity. To test the functional importance of the caspase pathway, we examined the effect of the broad-spectrum caspase inhibitor Idun 1965. Our studies clearly indicate that caspase inhibition markedly attenuates the nuclear changes associated with Gq-induced apoptosis, as assessed by nuclear chromatin condensation and internucleosomal DNA cleavage. We also found that caspase inhibitors block apoptosis induced by the addition of PGF₂ and ligands for other endogenous Gq-coupled receptors to cardiomyocytes overexpressing GqWT. Thus, caspases are essential mediators of apoptosis elicited by enhanced stimulation of Gq-signaling pathways.

Caspase inhibitors have been shown to reduce cardiomyocyte apoptosis and attenuate ischemia/reperfusion injury in rats.^{28 29} However, the functional rescue of surviving cardiomyocytes and its effect on sustained cardiac function was not thoroughly examined in these studies. Caspases would be viable therapeutic targets for heart failure only if they could successfully prevent or delay the functional changes associated with cardiac decompensation. Thus, although inhibiting caspases may significantly attenuate the ultimate apoptotic nuclear events induced by a variety of stimuli, it is not clear that the surviving myocytes would maintain normal cell function.

Our experiments provide a basis for questioning the ability of caspase inhibitors to preserve myocyte function in vivo. Specifically, we demonstrate that in GqQ209L-induced apoptosis, redistribution of cyto c to the cytosol, indicative of mitochondrial dysfunction, occurs despite inactivation of caspases. We have also noted that collapse of the _m is not prevented by caspase inhibition. This contrasts with what has been observed for Fas-induced cyto c release from mitochondria, which is prevented by inhibition of caspases and thereby seems to require caspase activity.³⁰ The limited effect of caspase inhibitors also demonstrates that the mitochondrial apoptotic cascade is proximal to and a potential mediator of caspase activation in Gq protein–induced apoptosis.

Cardiac muscle contains the highest volume density of mitochondria of any mammalian tissue. Therefore, it is unlikely that cardiomyocytes could maintain sufficient levels of ATP for extended periods of time without intact mitochondria. Apoptotic triggers upstream of caspase activation were analyzed for their role in Gq-induced cardiomyocyte apoptosis. Mitochondrial release of cyto c is a particularly attractive mechanism for caspase activation and induction of apoptosis. A critical element involved in the mitochondrial apoptotic pathway is a change in the permeability of the outer mitochondrial membrane. This may be regulated by the pore-forming capabilities of Bcl-2 family proteins or secondary to loss of _m. Loss of _m is proposed to occur in response to opening of the PT pore, a large nonselective channel in the inner membrane.¹¹ Loss of _m has been correlated in time with the point at which apoptosis can no longer be reversed by withdrawal of the stimulus.³¹ Thus, its disruption seems to lead to unalterable molecular events predisposing to cell death. Our studies demonstrate that this same nodal event occurs in response to enhanced Gq signaling.

The molecular triggers downstream of Gq and responsible for the catastrophic collapse in _m are currently unknown. Using BA, an inhibitor of PT pore formation, we demonstrated that this agent prevents the loss of _m and blocks cyto c release. Although the precise composition and structure of the PT pore are still undetermined, one of its components is the adenine nucleotide translocase. BA stabilizes the closed conformation of adenine nucleotide translocase and thereby inhibits PT pore opening.³² These data suggest that opening of the PT pore and the associated loss of _m are initiating apoptotic events caused by enhanced Gq signaling. The observation that BA also prevents cyto c release, cell shrinkage, and nuclear chromatin condensation confirms that these are sequelae of PT pore opening. Cyclosporin A has also been observed to prevent mitochondrial PT.^{12 33 34} However, in contrast to BA, cyclosporin A showed only a transient ability to block apoptotic responses in cardiac myocytes. This is consistent with findings by others demonstrating that cyclosporin A can prevent loss of _m in short-term experiments (30 to 60 minutes) but fails to maintain _m over longer time periods.¹²

Bcl-2 family proteins have also been implicated as regulators of mitochondrial function and PT pore formation.^{33 35} We find dramatic changes in expression of several Bcl-2 family proteins in myocytes expressing activated Gq, and it is likely that some of these changes play a significant role in the apoptotic process. However, expression of Bcl-xl or Bcl-2 at high levels did not prevent apoptosis in response to enhanced Gq signaling. The role of increased Bad and possible changes in other Bcl-2 family proteins in Gq-induced cardiomyocyte apoptosis are currently under additional investigation.

In conclusion, the evidence presented here demonstrates a pivotal role for the mitochondria in cardiac myocyte apoptosis induced by enhanced Gq signaling. Our studies with BA indicate that interruption of the apoptotic cascade at proximal points, such as the mitochondrial PT pore, not only promotes cell survival but preserves mitochondrial integrity, as assessed by cyto c release and maintenance of _m. Maintenance of mitochondrial oxidative metabolism in cardiac myocytes is essential to sustaining function. Therefore, the mitochondria are critical targets for development of therapeutic strategies to attenuate myocyte loss while preserving cardiac function and preventing heart failure. The cellular model described here provides a basis for understanding how stress-induced stimuli might alter mitochondrial permeability and allows us to examine the ability of potential therapeutic interventions to rescue cardiomyocyte function.

	Acknowledgments

 
This study was supported by National Institutes of Health grants HL-28143 and HL46345 (to J.H.B.) and an American Heart Association Beginning Grant-in-Aid (to J.W.A.). We thank Dennis Young for help with flow cytometry, Dr Jim Feramisco of the UCSD Cancer Center Imaging Core for help with image capture, and Alex DeCastro, Jon Genetti, and David R. Nadeau of the SDSC for 3-D volume rendering.

Received June 30, 2000; revision received October 19, 2000; accepted October 19, 2000.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 
1. LaMorte VJ, Thorburn J, Absher D, Spiegel AM, Brown JH, Chien KR, Feramisco JR, Knowlton KU. G_q- and Ras-dependent pathways mediate hypertrophy of neonatal rat ventricular myocytes following ₁-adrenergic stimulation. J Biol Chem. 1994;269:13490–13496.[Abstract/Free Full Text]

2. Sadoshima J, Qiu Z, Morgan JP, Izumo S. Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, MAP kinase and 90-kD S6 kinase in cardiac myocytes: the critical role of Ca²⁺-dependent signaling. Circ Res. 1995;76:1–15.[Abstract/Free Full Text]

3. Adams JW, Sah VP, Henderson SA, Brown JH. Tyrosine kinase and Jun NH₂-terminal kinase mediate hypertrophic responses to prostaglandin F₂ in cultured neonatal rat ventricular myocytes. Circ Res. 1998;83:167–178.[Abstract/Free Full Text]

4. Shubeita HE, McDonough PM, Harris AN, Knowlton KU, Glembotski CC, Brown JH, Chien KR. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes: a paracrine mechanism for myocardial cell hypertrophy. J Biol Chem. 1990;265:20555–20562.[Abstract/Free Full Text]

5. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW. Enhanced G_q signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci U S A. 1998;95:10140–10145.[Abstract/Free Full Text]

6. D’Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, Dorn GW. Transgenic G_q overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci U S A. 1997;94:8121–8126.[Abstract/Free Full Text]

7. Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, Neer EJ. Transient cardiac expression of constitutively active G_q leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci U S A. 1998;95:13893–13898.[Abstract/Free Full Text]

8. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG, Anversa P. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol. 1997;29:859–870.[Medline] [Order article via Infotrieve]

9. Ju H, Zhao S, Tappia PS, Panagia V, Dixon IMC. Expression of Gq and PLC-ß in scar and border tissue in heart failure due to myocardial infarction. Circulation. 1998;97:892–899.[Abstract/Free Full Text]

10. Hunter JJ, Grace A, Chien, KR, Molecular and cellular biology of cardiac hypertrophy and failure. In: Chien KR, ed. Molecular Basis of Cardiovascular Disease. Philadelphia, Pa: WB Saunders; 1999:211–250.

11. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309–1312.[Abstract/Free Full Text]

12. Zamzami N, Marchetti P, Castedo M, Hirsch T, Susin SA, Masse B, Kroemer G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 1996;384:53–57.[Medline] [Order article via Infotrieve]

13. Narula J, Pandey P, Arbustini E, Haider N, Narula N, Kolodgie FD, Dal Bello B, Semigran MJ, Bielsa-Masdeu A, Dec GW, Israels S, Ballester M, Virmani R, Saxena S, Kharbanda S. Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A. 1999;96:8144–8149.[Abstract/Free Full Text]

14. Bialik S, Cryns VL, Drincic A, Miyata S, Wollowick AL, Srinivasan A, Kitsis RN. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ Res. 1999;85:403–414.[Abstract/Free Full Text]

15. Malhotra R, Brosius FC. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J Biol Chem. 1999;274:12567–12575.[Abstract/Free Full Text]

16. Cook SA, Sugden PH, Clerk A. Regulation of Bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes. Circ Res. 1999;85:940–949.[Abstract/Free Full Text]

17. von Harsdorf R, Li P-F, Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation. 1999;99:2934–2941.[Abstract/Free Full Text]

18. Iwaki K, Sukhatme VP, Shubeita HE, Chien KR. and ß Adrenergic stimulation induce distinct patterns of immediate early gene expression in neonatal rat myocardial cells: fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an ₁ mediated response. J Biol Chem. 1990;265:13809–13817.[Abstract/Free Full Text]

19. Shubeita HE, Martinson EA, Van Bilsen M, Chien KR, Brown JH. Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A. 1992;89:1305–1309.[Abstract/Free Full Text]

20. McDonough PM, Brown JH, Glembotski CC. Phenylephrine and endothelin differentially stimulate cardiac PI hydrolysis and ANF expression. Am J Physiol. 1993;264:H625–H630.[Abstract/Free Full Text]

21. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, ed. Methods in Molecular Biology: Gene Transfer and Expression Protocols. Vol 7. Clifton, NJ: Humana Press; 1991:109–128.

22. Huang S, Deerinck TJ, Ellisman MH, Spector DL. In vivo analysis of the stability and transport of nuclear poly(A)+ RNA. J Cell Biol. 1994;126:877–899.[Abstract/Free Full Text]

23. Venkatakrishnan G, Exton JH. Identification of determinants in the -subunit of G_q required for phospholipase C activation. J Biol Chem. 1996;271:5066–5072.[Abstract/Free Full Text]

24. Natori S, Selzner M, Valentino KL, Fritz LC, Srinivasan A, Clavian PA, Gores GJ. Apoptosis of sinusoidal endothelial cells occurs during live preservation injury by a caspase-dependent mechanism. Transplantation. 1999;68:89–96.[Medline] [Order article via Infotrieve]

25. Reers M, Smiley S, Mottola-Hartshorn C, Chen A, Lin M, Chen L. Mitochondrial membrane potential monitored by JC-1 dye. Methods Enzymol. 1995;260:406–417.[Medline] [Order article via Infotrieve]

26. Yue T-L, Wang C, Rominic A, Kikly K, Keller P, DeWolf W, Hart T, Thomas H, Storer B, Gu J-L, Wang X, Feuerstein G. Staurosporine-induced apoptosis in cardiomyocytes: a potential role of caspase-3. J Mol Cell Cardiol. 1998;30:495–507.[Medline] [Order article via Infotrieve]

27. Black S, Huang J, Rezaiefar P, Radinovic S, Eberhart A, Nicholson D, Rodger I. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat. J Mol Cell Cardiol. 1998;30:733–742.[Medline] [Order article via Infotrieve]

28. Yaoita H, Ogawa K, Maehara K, Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 1998;87:276–281.

29. Holly TA, Drincic A, Byun Y, Nakamura S, Harris K, Klocke FJ, Cryns VL. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol. 1999;31:1709–1715.[Medline] [Order article via Infotrieve]

30. Vander-Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xl regulates the membrane potential and volume homeostasis of mitochondria. Cell. 1997;91:627–637.[Medline] [Order article via Infotrieve]

31. Kroemer G, Dallaporta B, Resche-Rignon M. the mitochondrial death/life regulator in apoptosis, and necrosis. Annu Rev Physiol.. 1998;60:619–642.[Medline] [Order article via Infotrieve]

32. Scheffler IE. Mitochondrial electron transport and oxidative phosphorylation. In: Mitochondria. New York, NY: Wiley-Liss; 1999:141–245.

33. Marzo I, Brenner C, Zamzami N, Jürgensmeier JM, Susin SA, Vieira HLA, Prevost M-C, Xie Z, Matsuyama S, Reed JC, Kroemer G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 1998;281:2027–2031.[Abstract/Free Full Text]

34. Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H, Tsujimoto Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci U S A. 1998;95:14681–14686.[Abstract/Free Full Text]

35. Brenner C, Cadiou H, La Vieira H, Zanzami N, Marzo I, Xie Z, Leber B, Andrews D, Duclohier H, Reed JC, Kroemer G. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene. 2000;19:329–336.[Medline] [Order article via Infotrieve]

This article has been cited by other articles:

				S. Javadov, M. Karmazyn, and N. Escobales Mitochondrial Permeability Transition Pore Opening as a Promising Therapeutic Target in Cardiac Diseases J. Pharmacol. Exp. Ther., September 1, 2009; 330(3): 670 - 678. [Abstract] [Full Text] [PDF]

				S. Miyamoto, M. Rubio, and M. A. Sussman Nuclear and mitochondrial signalling Akts in cardiomyocytes Cardiovasc Res, May 1, 2009; 82(2): 272 - 285. [Abstract] [Full Text] [PDF]

				Y.-M. Lu, F. Han, N. Shioda, S. Moriguchi, Y. Shirasaki, Z.-H. Qin, and K. Fukunaga Phenylephrine-Induced Cardiomyocyte Injury Is Triggered by Superoxide Generation through Uncoupled Endothelial Nitric-Oxide Synthase and Ameliorated by 3-[2-[4-(3-Chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxyindazole (DY-9836), a Novel Calmodulin Antagonist Mol. Pharmacol., January 1, 2009; 75(1): 101 - 112. [Abstract] [Full Text] [PDF]

				A. Diwan, J. Wansapura, F. M. Syed, S. J. Matkovich, J. N. Lorenz, and G. W. Dorn II Nix-Mediated Apoptosis Links Myocardial Fibrosis, Cardiac Remodeling, and Hypertrophy Decompensation Circulation, January 22, 2008; 117(3): 396 - 404. [Abstract] [Full Text] [PDF]

				A. B. Gustafsson and R. A. Gottlieb Heart mitochondria: gates of life and death Cardiovasc Res, January 15, 2008; 77(2): 334 - 343. [Abstract] [Full Text] [PDF]

				T. H. Tran, P. Andreka, C. O. Rodrigues, K. A. Webster, and N. H. Bishopric Jun Kinase Delays Caspase-9 Activation by Interaction with the Apoptosome J. Biol. Chem., July 13, 2007; 282(28): 20340 - 20350. [Abstract] [Full Text] [PDF]

				C. K. Means, C.-Y. Xiao, Z. Li, T. Zhang, J. H. Omens, I. Ishii, J. Chun, and J. H. Brown Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2944 - H2951. [Abstract] [Full Text] [PDF]

				D. P. Del Re, S. Miyamoto, and J. H. Brown RhoA/Rho Kinase Up-regulate Bax to Activate a Mitochondrial Death Pathway and Induce Cardiomyocyte Apoptosis J. Biol. Chem., March 16, 2007; 282(11): 8069 - 8078. [Abstract] [Full Text] [PDF]

				S.-D. Lee, C.-H. Chu, E.-J. Huang, M.-C. Lu, J.-Y. Liu, C.-J. Liu, H.-H. Hsu, J. A. Lin, W.-W. Kuo, and C.-Y. Huang Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E306 - E314. [Abstract] [Full Text] [PDF]

				M. Obreztchikova, H. Elouardighi, M. Ho, B. A. Wilson, Z. Gertsberg, and S. F. Steinberg Distinct Signaling Functions for Shc Isoforms in the Heart J. Biol. Chem., July 21, 2006; 281(29): 20197 - 20204. [Abstract] [Full Text] [PDF]

				S. Miyamoto, A. L. Howes, J. W. Adams, G. W. Dorn II, and J. H. Brown Ca2+ Dysregulation Induces Mitochondrial Depolarization and Apoptosis: ROLE OF Na+/Ca2+ EXCHANGER AND AKT J. Biol. Chem., November 18, 2005; 280(46): 38505 - 38512. [Abstract] [Full Text] [PDF]

				R. D. Peavy, K. B. Hubbard, A. Lau, R. B. Fields, K. Xu, C. J. Lee, T. T. Lee, K. Gernert, T. J. Murphy, and J. R. Hepler Differential Effects of Gq{alpha}, G14{alpha}, and G15{alpha} on Vascular Smooth Muscle Cell Survival and Gene Expression Profiles Mol. Pharmacol., June 1, 2005; 67(6): 2102 - 2114. [Abstract] [Full Text] [PDF]

				M. Faadiel Essop and L. H. Opie Metabolic therapy for heart failure Eur. Heart J., October 2, 2004; 25(20): 1765 - 1768. [Full Text] [PDF]

				D. Onan, L. Pipolo, E. Yang, R. D. Hannan, and W. G. Thomas Urotensin II Promotes Hypertrophy of Cardiac Myocytes via Mitogen-Activated Protein Kinases Mol. Endocrinol., September 1, 2004; 18(9): 2344 - 2354. [Abstract] [Full Text] [PDF]

				V. P.M van Empel and L. J De Windt Myocyte hypertrophy and apoptosis: a balancing act Cardiovasc Res, August 15, 2004; 63(3): 487 - 499. [Abstract] [Full Text] [PDF]

				M. Mayorga, N. Bahi, M. Ballester, J. X. Comella, and D. Sanchis Bcl-2 Is a Key Factor for Cardiac Fibroblast Resistance to Programmed Cell Death J. Biol. Chem., August 13, 2004; 279(33): 34882 - 34889. [Abstract] [Full Text] [PDF]

				T. Zhang, S. Miyamoto, and J. H. Brown Cardiomyocyte Calcium and Calcium/Calmodulin-dependent Protein Kinase II: Friends or Foes? Recent Prog. Horm. Res., January 1, 2004; 59(1): 141 - 168. [Abstract] [Full Text]

				K. A. Webster and N. H. Bishopric Apoptosis Inhibitors for Heart Disease Circulation, December 16, 2003; 108(24): 2954 - 2956. [Full Text] [PDF]

				Y. Hayakawa, M. Chandra, W. Miao, J. Shirani, J. H. Brown, G. W. Dorn II, R. C. Armstrong, and R. N. Kitsis Inhibition of Cardiac Myocyte Apoptosis Improves Cardiac Function and Abolishes Mortality in the Peripartum Cardiomyopathy of G{alpha}q Transgenic Mice Circulation, December 16, 2003; 108(24): 3036 - 3041. [Abstract] [Full Text] [PDF]

				A. L. Howes, J. F. Arthur, T. Zhang, S. Miyamoto, J. W. Adams, G. W. Dorn II, E. A. Woodcock, and J. H. Brown Akt-mediated Cardiomyocyte Survival Pathways Are Compromised by G{alpha}q-induced Phosphoinositide 4,5-Bisphosphate Depletion J. Biol. Chem., October 10, 2003; 278(41): 40343 - 40351. [Abstract] [Full Text] [PDF]

				A. Gonzalez, M. A Fortuno, R. Querejeta, S. Ravassa, B. Lopez, N. Lopez, and J. Diez Cardiomyocyte apoptosis in hypertensive cardiomyopathy Cardiovasc Res, September 1, 2003; 59(3): 549 - 562. [Abstract] [Full Text] [PDF]

				W. T. Pu, Q. Ma, and S. Izumo NFAT Transcription Factors Are Critical Survival Factors That Inhibit Cardiomyocyte Apoptosis During Phenylephrine Stimulation In Vitro Circ. Res., April 18, 2003; 92(7): 725 - 731. [Abstract] [Full Text] [PDF]

				Y. Pang, D. L. Hunton, P. Bounelis, and R. B. Marchase Hyperglycemia Inhibits Capacitative Calcium Entry and Hypertrophy in Neonatal Cardiomyocytes Diabetes, December 1, 2002; 51(12): 3461 - 3467. [Abstract] [Full Text] [PDF]

				M. A. Sussman, A. McCulloch, and T. K. Borg Dance Band on the Titanic: Biomechanical Signaling in Cardiac Hypertrophy Circ. Res., November 15, 2002; 91(10): 888 - 898. [Abstract] [Full Text] [PDF]

				A. M. Samarel IGF-1 Overexpression Rescues the Failing Heart Circ. Res., April 5, 2002; 90(6): 631 - 633. [Full Text] [PDF]

				K. Takuma, P. Phuagphong, E. Lee, K. Mori, A. Baba, and T. Matsuda Anti-apoptotic Effect of cGMP in Cultured Astrocytes. INHIBITION BY cGMP-DEPENDENT PROTEIN KINASE OF MITOCHONDRIAL PERMEABLE TRANSITION PORE J. Biol. Chem., December 14, 2001; 276(51): 48093 - 48099. [Abstract] [Full Text] [PDF]

				H. Ueda, R. Morishita, H. Itoh, S. Narumiya, K. Mikoshiba, K. Kato, and T. Asano Galpha 11 Induces Caspase-mediated Proteolytic Activation of Rho-associated Kinase, ROCK-I, in HeLa Cells J. Biol. Chem., November 2, 2001; 276(45): 42527 - 42533. [Abstract] [Full Text] [PDF]

				M. Xu, Y. Wang, A. Ayub, and M. Ashraf Mitochondrial KATP channel activation reduces anoxic injury by restoring mitochondrial membrane potential Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1295 - H1303. [Abstract] [Full Text] [PDF]

				G. Z. Feuerstein and D. Rozanski G Proteins and Heart Failure : Is G{alpha}q a Novel Target for Heart Failure? Circ. Res., December 8, 2000; 87(12): 1085 - 1086. [Full Text] [PDF]

This Article Abstract Full Text (PDF) Data Supplement Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Adams, J. W. Articles by Brown, J. H. Search for Related Content PubMed PubMed Citation Articles by Adams, J. W. Articles by Brown, J. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Apoptosis Cell signalling/signal transduction